About us
Cerba is a leading reference in specialised medical biology in France and internationally. For over 50 years, it has been leveraging its medical expertise and strong capacity for innovation to serve patients, healthcare professionals, and the pharmaceutical industry.
Our expertise
Since 1967, Cerba has been leveraging its expertise and innovation to serve healthcare. Recognized in France and internationally, our laboratory is a leading player in specialised medical biology, offering a high level of excellence for patients and healthcare professionals.
Training and resources
We are committed daily to placing medical biology at the heart of the care pathway to improve patient management in terms of prevention, diagnosis, and monitoring of diseases. This involves medical and technical expertise, innovation, as well as a range of training programs and a constantly evolving array of services and tools.
Our news
Contact us

fgf23 intact

The exam, in brief

Select a nature

Price excluding nomenclature

63 €

Technical

Chemiluminescence

Average time to render Frequency

1 maximum day

Technical frequency

1/w

What should I send?

Preparation of the sample

Temperature

Congelé

Selected nature

EDTA plasma

Quantity

1 ml

Technical

Chemiluminescence

Average turnouroud time

Realisation frequency

1/w

Additional information

Comments

Do not freeze tubes with separative gel, aliquote plasma EDTA before freezing (< 1 hour).

Discover our medical news

Browse the news

Need help?

Diagnosis, classification, choice and monitoring of treatment, ...
From the selection of exams to the interpretation of results and therapeutic recommendations, our experts are there to help you. Ask for their advice.

Contact an expert

fgf23 intact

The exam, in brief

Select a nature

Price excluding nomenclature

Technical

Average time to render Frequency

Technical frequency

LCSD Code

Cerba Code

What should I send?

Preparation of the sample

Temperature

Selected nature

Quantity

Technical

Average turnouroud time

Realisation frequency

Additional information

Comments

Discover our medical news

CLS#74 The Kappa Index: a new biomarker in the diagnosis of Multiple Sclerosis (MS)

CEO Cerba HealthCare Nomination

[REPLAY] Hemochromatosis: A genetic disease in full evolution

[WEBINAR REPLAY – ONCO] Lung Cancer Testing: Guidelines, Pitfalls, and Reimbursement

Need help?